Gerald Clarke
More content by Gerald Clarke
The FDA are Taking Cybersecurity in Medical Devices Seriously and So Should You
October 02 by Gerald ClarkeMedical devices are undergoing a technical transformation in terms of software, interconnectivity and interoperability. This increase of function comes with an increase in risk from cybersecurity th...
GSK and Novartis Agree Multi-Billion Asset Swap
April 24 by Gerald ClarkePharma restructuring continues unabated and the latest deals to be announced are some of the biggest yet. Most of the major players in the market have undergone dramatic shifts in how they do busine...
Extraordinary New Tech Demos Impress at TEDMED
April 24 by Gerald ClarkeTED talks have grown a huge reputation for inspirational in innovative talks in recent years and now register millions of views every day. This Monday, I was lucky enough to attend the TEDMED confer...
The Future of Biosimilars - A Case of Untapped Potential?
March 26 by Gerald ClarkeThe patents on a majority of the top-selling biologic drugs currently on the market will have expired by 2020, an amount which may be equivalent to $67 billion. Can we expect then a rush of biosimil...
Fewer Robots, More Apps - An Interview with Jeff Hurst
March 25 by Gerald ClarkeThe informatics landscape is changing quickly and innovation could be the key to increasing efficiency. Jeff Hurst, Senior Scientist at the Hershey's Company talks us through these cha...
Care.data - How Not to Communicate a Complex Health Issue
March 21 by Gerald ClarkeTo start with an understatement: information is important. Information is so important that in some descriptions, it gives its name to the epoch we are living in: The Information Age. Acting without...
What Pharma can Learn from the Food & Beverage Industry -- An Interview with Pepsico's Steve Hills
March 12 by Gerald ClarkeThe pharma industry has a lot to learn from the food and beverage industry when it comes to contract manufacturing. To get to grips with this outsider's view, we spoke with Steve Hills, European Contr...
High Throughput Screening Market to Hit $19 Billion by 2018
March 12 by Gerald ClarkeHigh Throughput Screening is growing rapidly as it becomes essential for new sectors and old areas find new applications for it. According to a new report titled High Throughput Screening (HTS) Mark...
5 Things I Learned at Pharma Times’ PPRS Meeting
March 07 by Gerald ClarkeOn the 26thof February, I attended PharmaTimes’ PPRS and Value Based Assessment meeting. It was an eye opening experience to the depth of feeling being expressed around the UK government&rsquo...
From Tactical to Strategic Thinking; The Change in CMO Relationships - An Interview with Jim Browne
March 05 by Gerald ClarkeWhere can companies go wrong in their relationship with a CMO and what have been the major changes in these relationships in recent years? We spoke with Jim Browne, former Director of External Suppl...
Regulatory Bodies Discussing 'Three-Parent Embryos'
March 03 by Gerald ClarkeThree-parent embryos need a new name. Both the FDA and the UK government have recently opened up dialogues on the topic of mitochondrial donation to avert diseases caused by mitochondrial genetic defe...
Maintaining Public Trust in Biobanking - Time for True Transparency?
February 25 by Gerald ClarkeIn the digital environment, access and transparency are becoming increasingly common concerns. As technical industries, pharma and biotech have of course been involved in this debate. One of the rec...
